These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23621531)

  • 21. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facile one-pot fabrication of calcium phosphate-based composite nanoparticles as delivery and MRI contrast agents for macrophages.
    Nakamura M; Oyane A; Kuroiwa K; Shimizu Y; Pyatenko A; Misawa M; Numano T; Kosuge H
    Colloids Surf B Biointerfaces; 2018 Feb; 162():135-145. PubMed ID: 29190464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic nanoparticles: a novel platform for cancer theranostics.
    Singh A; Sahoo SK
    Drug Discov Today; 2014 Apr; 19(4):474-81. PubMed ID: 24140592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging.
    Das M; Mishra D; Dhak P; Gupta S; Maiti TK; Basak A; Pramanik P
    Small; 2009 Dec; 5(24):2883-93. PubMed ID: 19856326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Principles and applications of nanomaterial-based hyperthermia in cancer therapy.
    Kang JK; Kim JC; Shin Y; Han SM; Won WR; Her J; Park JY; Oh KT
    Arch Pharm Res; 2020 Jan; 43(1):46-57. PubMed ID: 31993968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced iron oxide nanotheranostics for multimodal and precision treatment of pancreatic ductal adenocarcinoma.
    Zhu L; Mao H; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1793. PubMed ID: 35396932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of mechanical properties of iron oxide nanoparticle-loaded functional nano-carrier on tumor targeting and imaging.
    Choi WI; Kim JY; Heo SU; Jeong YY; Kim YH; Tae G
    J Control Release; 2012 Sep; 162(2):267-75. PubMed ID: 22824783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
    Rosen JE; Chan L; Shieh DB; Gu FX
    Nanomedicine; 2012 Apr; 8(3):275-90. PubMed ID: 21930108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles.
    Wang S; He H; Mao Y; Zhang Y; Gu N
    Adv Sci (Weinh); 2024 May; 11(17):e2308298. PubMed ID: 38368274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron Oxide Nanoparticles-Based Vaccine Delivery for Cancer Treatment.
    Zhao Y; Zhao X; Cheng Y; Guo X; Yuan W
    Mol Pharm; 2018 May; 15(5):1791-1799. PubMed ID: 29570298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron oxide-based multifunctional nanoparticulate systems for biomedical applications: a patent review (2008 - present).
    El-Hammadi MM; Arias JL
    Expert Opin Ther Pat; 2015 Jun; 25(6):691-709. PubMed ID: 25800416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in the delivery of nanoparticle constructs: towards clinical translation.
    Ryan SM; Brayden DJ
    Curr Opin Pharmacol; 2014 Oct; 18():120-8. PubMed ID: 25450066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticles for cancer therapy using magnetic forces.
    Tietze R; Lyer S; Dürr S; Alexiou C
    Nanomedicine (Lond); 2012 Mar; 7(3):447-57. PubMed ID: 22385201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages.
    Rampersaud S; Fang J; Wei Z; Fabijanic K; Silver S; Jaikaran T; Ruiz Y; Houssou M; Yin Z; Zheng S; Hashimoto A; Hoshino A; Lyden D; Mahajan S; Matsui H
    Nano Lett; 2016 Dec; 16(12):7357-7363. PubMed ID: 27960523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
    Tyagi P; Subramony JA
    J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on current and potential nanoparticle cancer therapies.
    Rink JS; Plebanek MP; Tripathy S; Thaxton CS
    Curr Opin Oncol; 2013 Nov; 25(6):646-51. PubMed ID: 24097107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inorganic nanoparticles for cancer imaging and therapy.
    Huang HC; Barua S; Sharma G; Dey SK; Rege K
    J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.